SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Barclays Maintains Equal-Weight Rating on Insulet, Raises Target to $165

Barclays maintained its Equal-Weight rating on Insulet and raised its price target to $165 per share from $150.

PODD

Related stories